论文部分内容阅读
本刊已重点介绍了几类心血管药物的合理应用,鉴于目前国内药名混乱不统一,给临床尤其是基层人员造成用药困难,本文拟将国内已常用及已进入临床试验的新药(估计不久将上市),按分类介绍药名。并对国外新药研制情况作一简要介绍。本文中外文药名采用外文杂志、书籍使用的世界卫生组织发表的《药品国际非专利名称》(International Nonproprietary Names for Pharmaceutical Substances,简称INN),通常在药品说明书上除商品名外,均应附有INN药
This publication has highlighted the rational use of several types of cardiovascular drugs, given the current domestic pharmaceutical confusion is not uniform, to the clinical staff, especially the difficulties caused by the grass-roots staff, this article intends to domestic and has entered the clinical trials of commonly used drugs (estimated shortly Will be listed), introduced by name of the drug. And make a brief introduction of the development of new drug abroad. In this article, the foreign drug names are in foreign magazines, and the International Nonproprietary Names for Pharmaceutical Substances (INNs) published by the World Health Organization for the use of books are usually provided with the exception of trade names INN medicine